PURPOSE: We aimed to investigate the incidence of @entity7674 ( @entity7674 ) in @entity1 with @entity15091 ( @entity15091 ) and its effect on the success of behavioral interventions. We also aimed to identify predictive factors related to success of behavioral interventions. METHODS: A total of 163 @entity1 with @entity15091 and 160 @entity1 without @entity15091 were enrolled to study. Urinalysis, urine culture, biochemical evaluation, plain radiography and urinary system ultrasonography were performed before treatment. @entity1 with @entity15091 received behavioral interventions for 3  months. Response to behavioral interventions was analyzed according to the presence and absence of @entity7674 . Possible predictive factors for treatment success were also evaluated. RESULTS: Spina bifida occulta was detected in 47 (28.8  %) @entity1 at @entity15091 group and 24 (15.0  %) at control group (p  =  0.138). Non-monosymptomatic @entity15091 was more prevalent in @entity1 with @entity7674 (p  <  0.001), and response to the treatment was significantly lower (p  =  0.037). Presence of @entity7674 (OR 8.8, 95  % CI 3.1-25.6), @entity15091 severity (OR 7.2, 95  % CI 2.4-21.7) and @entity15091 frequency on 3-day voiding diary (OR 9.4, 95  % CI 3.7-24.3) were significantly related to the success. CONCLUSIONS: The presence of @entity7674 , severe @entity15091 and higher frequency of @entity15091 in voiding diary affect the response to behavioral interventions. Other treatment options such as medical treatment or enuresis alarm may be recommended for those @entity1 .

Nocturnal enuresis with XXXX : Does it interfere behavioral management success?

@entity1 :: ('9606', 'Species') :: ['children', 'Patients', 'patients'] @entity7674 :: ('MESH:D016136', 'Disease') :: ['SBO', 'spina bifida occulta'] @entity15091 :: ('MESH:D053206', 'Disease') :: ['nocturnal enuresis', 'NE']
@entity7674 :: (MESH:D016136,Disease) :: ['spina bifida occulta']
